Strata Critical Medical (SRTA) Receivables - Net (2020 - 2026)

Strata Critical Medical (SRTA) has 7 years of Receivables - Net data on file, last reported at $39.6 million in Q1 2026.

• Receivables - Net for Q1 2026 came in at $39.6 million, up 78.97% year-over-year; the trailing twelve-month figure through Mar 2026 was $39.6 million (up 78.97% YoY), and the FY2025 annual result was $40.0 million, up 101.58% from the prior year.
• Receivables - Net eased to $39.6 million in Q1 2026 per SRTA's latest filing, from $40.0 million in the prior quarter.
• Over five years, Receivables - Net peaked at $40.0 million in Q4 2025 and troughed at $6.0 million in Q1 2022.
• A 5-year average of $22.5 million and a median of $22.1 million in 2025 frame the typical range for Receivables - Net.
• The sharpest annual moves came in 2022 and 2025: Receivables - Net soared 464.95% in 2022, then retreated 6.04% in 2025.
• A 5-year view of Receivables - Net shows it stood at $10.9 million in 2022, then surged by 93.11% to $21.0 million in 2023, then dropped by 5.63% to $19.8 million in 2024, then jumped by 101.58% to $40.0 million in 2025, then slipped by 0.89% to $39.6 million in 2026.
• Business Quant data shows SRTA's Receivables - Net at $39.6 million in Q1 2026, $40.0 million in Q4 2025, and $37.5 million in Q3 2025.